Skip to main content

1 Result(s)

within E Almahasnah Remove this filter

and

  1. Article

    Open Access

    Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia

    Ofatumumab is a humanized anti-CD20 monoclonal antibody that has been approved by the FDA for the treatment of patients with chronic lymphocytic leukemia. We conducted a phase II single-arm study at a single c...

    J E Castro, M Y Choi, T Carvajal, E Almahasnah, J Chang, D F James… in Blood Cancer Journal (2014)

    Download PDF (475 KB) View Article